Statements (37)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antihistamine |
| gptkbp:approvedBy |
1990s
|
| gptkbp:ATCCode |
R01AC03
|
| gptkbp:brand |
Astelin
Astepro Optivar |
| gptkbp:CASNumber |
58581-89-8
|
| gptkbp:discoveredBy |
Meda Pharma
|
| gptkbp:eliminationHalfLife |
22 hours
|
| gptkbp:excretion |
urine
feces |
| gptkbp:hasMolecularFormula |
C22H24ClN3O
|
| https://www.w3.org/2000/01/rdf-schema#label |
azelastine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
histamine H1 receptor antagonist
|
| gptkbp:meltingPoint |
225-226°C
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
2267
2179 CHEMBL1201312 DB00972 |
| gptkbp:routeOfAdministration |
nasal
ophthalmic |
| gptkbp:sideEffect |
headache
drowsiness bitter taste nasal irritation |
| gptkbp:synonym |
4-[(4-chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone
|
| gptkbp:UNII |
L16O9V2TSM
|
| gptkbp:usedFor |
allergic rhinitis
allergic conjunctivitis vasomotor rhinitis |
| gptkbp:bfsParent |
gptkb:R06AE07
gptkb:antihistamine |
| gptkbp:bfsLayer |
6
|